Islet Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-491,940
Closed -$4.93M 292
2021
Q2
$4.93M Hold
491,940
0.14% 132
2021
Q1
$4.94M Sell
491,940
-8,060
-2% -$85.7K 0.12% 139
2020
Q4
$5.25M Buy
+500,000
New +$5.22M 0.24% 94

Other funds holding MTACU

Islet Management's MTACU Position: Q3 2021 in Review

Islet Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 491,940 shares — an estimated $4.93M sold.

Islet Management first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $5.25M in Q4 2020. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.

  • Islet Management reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Islet Management sold 491,940 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $4.93M.
  • Islet Management first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Islet Management's MedTech Acquisition Corporation Unit position peaked at $5.25M in Q4 2020.
  • 20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.

Based on Islet Management's 13F filing for Q3 2021, filed 15 Nov 2021.